citric acid, anhydrous has been researched along with Leukemia, Myeloid, Acute in 3 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "IDH2 mutation is an oncogenic event in acute myeloid leukemia (AML) due to the generation of 2-hydroxyglutarate." | 1.72 | Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy. ( Glorieux, C; Huang, P; Li, J; Li, Y; Lu, W; Qiao, S; Tian, J; Wen, S; Zeng, P; Zhang, H, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zeng, P | 1 |
| Lu, W | 1 |
| Tian, J | 1 |
| Qiao, S | 1 |
| Li, J | 1 |
| Glorieux, C | 1 |
| Wen, S | 1 |
| Zhang, H | 1 |
| Li, Y | 1 |
| Huang, P | 1 |
| Sun, J | 1 |
| Xia, F | 1 |
| Zhang, S | 1 |
| Zhang, B | 1 |
| Guan, Y | 1 |
| Hu, X | 1 |
| Xue, P | 1 |
| Yang, S | 1 |
| Zhou, Y | 1 |
| Ling, D | 1 |
| Li, F | 1 |
| Devauchelle, P | 1 |
| Page, M | 1 |
| Brun, P | 1 |
| Ber, CE | 1 |
| Crozon, J | 1 |
| Baillon, JJ | 1 |
| Allaouchiche, B | 1 |
| Rimmelé, T | 1 |
3 other studies available for citric acid, anhydrous and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy.
Topics: Animals; Catalysis; Citric Acid; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Lipids; | 2022 |
A Selective Nano Cell Cycle Checkpoint Inhibitor Overcomes Leukemia Chemoresistance.
Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Citric Acid; Drug Design; | 2023 |
[Continuous haemodialysis with citrate anticoagulation in patients with liver failure: three cases].
Topics: Acute Kidney Injury; Anticoagulants; Calcium; Citric Acid; Fatal Outcome; Female; Hepatitis C; Human | 2012 |